Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection | Zendy

Jacques Azzi | Zendy; Andreas Kyvernitakis | Zendy; Dimpy P. Shah | Zendy; Lynn El Haddad | Zendy; Sminil N. Mahajan | Zendy; Shashank S. Ghantoji | Zendy; Ella Heredia-Ariza | Zendy; Roy F. Chemaly | Zendy

Open Access

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection

Author(s) -

Jacques Azzi,

Andreas Kyvernitakis,

Dimpy P. Shah,

Lynn El Haddad,

Sminil N. Mahajan,

Shashank S. Ghantoji,

Ella Heredia-Ariza,

Roy F. Chemaly

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky311

Subject(s) - ribavirin , leukopenia , medicine , respiratory system , virus , pneumovirus , virology , immunology , intensive care medicine , viral disease , paramyxoviridae , chemotherapy , hepatitis c virus

Respiratory syncytial virus (RSV) infection causes morbidity and mortality in cancer patients. However, studies describing this infection in patients with haematological malignancies are scarce. We sought to evaluate the clinical impact of RSV infection on this patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research